Infectious diseases and autoimmunity

Journal of Infection in Developing Countries

Volumn 5, Issue 10, 2011, Pages 679-687

  Delogu, Lucia G ^a   Deidda, Silvia ^a   Delitala, Giuseppe ^a   Manetti, Roberto ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Autoimmune disease; Autoreactive lymphocyte; Bacterial infection; Bystander activation; Epitope spreading; Molecular mimicry; Viral infection

Indexed keywords

EPITOPE; SUPERANTIGEN;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BYSTANDER EFFECT; DISEASE EXACERBATION; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MOLECULAR MECHANICS; MOLECULAR MIMICRY; NONHUMAN; REVIEW; VIRUS INFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); SCOPUS;

EID: 80054799077     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2061     Document Type: Review

References (77)

1. Samaras V, Rafailidis PI, Mourtzoukou EG, Peppas G, Falagas ME (2010) Chronic bacterial and parasitic infections and cancer: a review. J Infect Dev Ctries 4: 267-281.
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens--Part B: biological agents. WHO International Agency for Research on Cancer Monograph Working Group. Lancet Oncol 10: 321-322.
3. Zur Hausen H (2006) Streptococcus bovis: causal or incidental involvement in cancer of the colon? Int J Cancer 119: xi-xii.
4. Rioux JD and Abbas AK (2005) Paths to understanding the genetic basis of autoimmune disease. Nature 435: 584-589.
5. Bjorses P, Aaltonen J, Horelli-Kuitunen N, Yaspo ML, Peltonen L (1998) Gene defect behind APECED: a new clue to autoimmunity. Hum Mol Genet 7: 1547-1553.
6. Walker LS and Abbas AK (2002) The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2: 11-19.
7. Münz C, Lünemann JD, Getts MT, Miller SD (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol; 9: 246-258.
8. Selgrade MK, Cooper GS, Germolec DR, Heindel JJ (1999) Linking environmental agents and autoimmune disease: an agenda for future research. Environ Health Perspect; 107 (Suppl. 5): 811-813.
9. Rose NR and Bona C (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14: 426-430.
10. Oldstone MBA (1998) Molecular mimicry and immune mediated diseases. FASEB J 12: 1255-1265.
11. Theofilopoulos AN, and Kono DH (1998) Mechanisms and genetics of autoimmunity. Ann NY Acad Sci 841: 225-235.
12. Lori JA and Inman RD (1999) Molecular mimicry and autoimmunity. N Engl J Med 341: 2068-2074.
13. Benoist C and Mathis D (2001) Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2: 797-801.
14. Wucherpfennig KW (2001) Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108: 1097-1104.
15. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM (1999) Chlamydia infections and heart disease linked through antigenic mimicry. Science 283: 1335-1339.
16. Rose NR and Mackay IR (2000) Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 57: 542-551.
17. Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B, Straus SE, McFarland HF, Houghten R, Simon R, Pinilla C, Martin R (1999) Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med 5: 1375-1382.
18. Martin R, Gran B, Zhao Y, Markovic-Plese S, Bielekova, B, Marques A, Sung MH, Hemmer B, Simon R, McFarland HF, Pinilla C (2001) Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease. J Autoimmun 16: 187-192.
19. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
20. Lehmann PV, Forsthuber T, Miller A, Sercarz EE (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155-157.
21. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3: 1133-1136.
22. Schrer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P (1993) Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol. 9: 101-128.
23. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S (2008) Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3: 352-363.
24. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW (2008) Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu Rev Immunol 26: 171-203.
25. Fujinami RS, Oldstone MB, Wroblewska Z, Frankel ME, Koprowski H (1983) Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 80: 2346-2350.
26. Fujinami RS and Oldstone MB (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230: 1043-1045.
27. Wucherpfennig KW and Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695-705.
28. Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L (2002) A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3: 940-943.
29. Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, Thomsen AR, Cardon LR, Bell JI, Fugger L (2006) Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 443: 574-577.
30. Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H (1998) Molecular mimicry by herpes simplex virustype 1: autoimmune disease after viral infection. Science 279: 1344-1347.
31. Deshpande SP, Lee S, Zheng M, Song B, Knipe D, Kapp JA, Rouse BT (2001) Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J Virol 75: 3077-3088.
32. Honeyman MC, Stone NL, Falk BA, Nepom G, Harrison LC (2010) Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 184: 2204-2210.
33. Agabi YA, Banwat EB, Mawak JD, Lar PM, Dashe N, Dashen MM, Adoga MP, Agabi FY, Zakari H (2010) Seroprevalence of herpes simplex virus type-2 among patients attending the Sexually Transmitted Infections Clinic in Jos, Nigeria. J Infect Dev Ctries 4: 572-575.
34. Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti VA, Gauntt CJ (1992) Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A 89: 1320-1324.
35. Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK, Miller SD, Oldstone MB, von Herrath MG (2004) A viral epitope that mimics a self-antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 114: 1290-1298.
36. Mokhtarian F, Zhang Z, Shi Y, Gonzales E, Sobel RA (1999) Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol 95: 43-54.
37. Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, Crawley R (1995) Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol 154: 2983-2995.
38. Lawson CM (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 57: 552-560.
39. Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC (2005) Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 201: 703-711.
40. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E (2005) Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 201: 1659-1667.
41. Lovett-Racke AE, Trotter JL, Lauber J, Perrin PJ, June CH, Racke MK (1998) Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest 101: 725-730.
42. Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R (2001) CD4+CD28- costimulation independent T cells in multiple sclerosis. J Clin Invest 108: 1185-1194.
43. Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, Oksenberg JR (1999) B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 163: 5133-5144.
44. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schröder R, Deckert M, Schmidt S, Ravid R, Rajewsky K (2000) Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192: 393-404.
45. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, Wekerle H, Hohlfeld R, Goebels N (2004) Multiple clerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A 101: 2428-2433.
46. Meinl E, Weber F, Drexler K, Morelle C, Ott M, Saruhan-Direskeneli G, Goebels N, Ertl B, Jechart G, Giegerich G (1993) Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 92: 2633-2643.
47. Goebels N, Hofstetter H, Schmidt S, Brunner C, Wekerle H, Hohlfeld R (2000) Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain 123: 508-518.
48. Muraro PA, Wandinger KP, Bielekova B, Gran B, Marques A, Utz U, McFarland HF, Jacobson S, Martin R(2003) Molecular tracking of antigen-specific T cell clones in neurological immunemediated disorders. Brain 126: 20-31.
49. Thacker EL, Mirzaei F, Ascherio A (2006) Infectious mononucleosis and risk for multiple sclerosis: a metaanalysis. Ann Neurol 59: 499-503.
50. Nielsen TR, Rostgaard K, Nielsen NM, Koch-Henriksen N, Haahr S, Sørensen PS, Hjalgrim H (2007) Multiple sclerosis after infectious mononucleosis. Arch Neurol 64: 72-75.
51. Nielsen TR, Rostgaard K, Askling J, Steffensen R, Oturai A, Jersild C, Koch-Henriksen N, Sørensen PS, Hjalgrim H (2009) Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler 15: 431-436.
52. Lünemann JD, Jelcić I, Roberts S, Lutterotti A, Tackenberg B, Martin R, Münz C (2008) EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2. J Exp Med 205: 1763-1773.
53. Toh BH, van Driel IR, and Gleeson PA (1997) Pernicious anemia. N Engl J Med 337: 1441-8.
54. Karlsson FA, Burman P, Loof L, and Mardh S (1988) Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+K+-adenosine triphosphatase of the stomach. J Clin Invest 81: 475-479.
55. Toh BH, van Driel IR, and Gleeson PA (1992) Autoimmune gastritis: tolerance and autoimmunity to the gastric H+K+ ATPase (proton pump). Autoimmunity 13: 165-172.
56. D'Elios MM, Bergman MP, Azzurri A, Amedei A, Benagiano M, De Pont JJ, Cianchi F, Vandenbroucke-Grauls CM, Romagnani S, Appelmelk BJ, and Del Prete G (2001) H+K+-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 120: 377-386.
57. Yamaoka Y (2008) Increasing evidence of the role of Helicobacter pylori SabA in the pathogenesis of gastroduodenal disease. J Infect Dev Ctries 2: 174-1781.
58. Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, van der Zee R, Telford JL, Vandenbroucke-Grauls CM, D'Elios MM, Del Prete G (2003) Molecular mimicry between Helicobacter pylori antigens and H+, K+ -adenosine triphosphatase in human gastric autoimmunity. J Exp Med 198: 1147-1156.
59. Zipris D, Lien E, Xie JX, Greiner DL, Mordes JP, Rossini AA (2005) TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 174: 131-142.
60. Walker LS, Abbas AK (2002) The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2: 11-19.
61. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD (1995) Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 182: 75-85.
62. Yu M, Johnson JM, Tuohy VK (1996) A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptidespecific therapy after onset of clinical disease. J Exp Med 183: 1777-1788.
63. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72.
64. Cho SN, Gormus BJ, Xu K, Bohm RP Jr., Walsh GP, Meyers WM, Kim JD (1993) Serologic responses to nerve antigens in sooty mangabey monkeys with experimental leprosy. Int J Lep Other Mycobact Dis 61: 236-244.
65. Kim JD, Cho SN, Park S, Walsh GP (1997) Detection of antibodies to nerve antigens in sera from leprosy patients and relevance to the nerve damage. Korean J Immunol 19: 463-70.
66. Singh K, Singh B, Ray PC (2010) Anti-ceramide antibodies in leprosy: marker for nerve damage? J Infect Dev Ctries 4: 378-381.
67. Wucherpfennig KW (2001) Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108: 1097-1104.
68. Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, Steinman L (1993) Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365: 642-644.
69. Cole BC and Griffiths MM (1993) Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arthritis Rheum 36: 994-1002.
70. Dalwadi H, Wei B, Kronenberg M, Sutton CL, Braun J (2001) The Crohn's disease-associated bacterial protein I2 is a novel enteric T cell superantigen. Immunity 15: 149-158.
71. Ercolini AM and Miller SD (2008) The role of infections in autoimmune disease. Clin Exp Immunol 155: 1-15.
72. Deng GM and Tsokos GC (2008) Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. J Immunol 181: 4019-4026.
73. Olson JK, Ludovic Croxford J, Miller SD (2004) Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry. Mol Immunol 40: 1103-1108.
74. Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19: 80-94.
75. Evans CF, Horwitz MS, Hobbs MV, Oldstone MB (1996) Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 184: 2371-2384.
76. Scotet E, David-Ameline J, Peyrat MA, Moreau-Aubry A, Pinczon D, Lim A, Even J, Semana G, Berthelot JM, Breathnach R, Bonneville M, Houssaint E (1996) T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 184: 1791-1800.
77. Scotet E, Peyrat MA, Saulquin X, Retiere C, Couedel C, Davodeau F, Dulphy N, Toubert A, Bignon JD, Lim A, Vie H, Hallet MM, Liblau R, Weber M, Berthelot JM, Houssaint E, Bonneville M (1999) Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur J Immunol 29: 973-985.